TFF2 and brain edema: Furthermore, the pattern of SP immunoreactivity, as well as the observed decreases in BBB permeability and brain water content are consistent among these studies [10], [12], highlighting the reproducibility of these results in both immune-competent and deficient species, and thus the translational potential of SP antagonists as a therapy for cerebral edema.